Shozo Kobori - Concepedia

Author

Shozo Kobori

Kumamoto University

Also Known As

SHOZO KOBORI, Shozo KOBORI, Shozo Kobori

Publications

978

Citations

H-Index

Concepts

All Affiliations

Kumamoto University Kumamoto Medical Center Kumamoto University Hospital Kaketsuken (Japan)Naruto University of Education

About

Shozo Kobori is an author at Kumamoto University specializing in medicine, metabolic syndrome, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	371
2	Cell Biology	4	4	186
3	Health Sciences	3	3	43
4	Biochemistry	3	3	106
5	Public Health	2	2	87

Shozo Kobori

Publications

840

Citations

H-Index

Page 1

	Year	Citations
Two Intracellular Signaling Pathways for Activation of Protein Kinase C Are Involved in Oxidized Low-Density Lipoprotein–Induced Macrophage Growth Takeshi Matsumura, Masakazu Sakai, Shozo Kobori, Arteriosclerosis Thrombosis and Vascular Biology	1997	101
The Scavenger Receptor Serves as a Route for Internalization of Lysophosphatidylcholine in Oxidized Low Density Lipoprotein-induced Macrophage Proliferation Masakazu Sakai, Akira Miyazaki, Hideki Hakamata, Journal of Biological Chemistry	1996	100
HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein Masakazu Sakai, Shozo Kobori, Takeshi Matsumura, Atherosclerosis InflammationOxysterolBiochemistryLipid PeroxidationImmunology	1997	83
Lysophosphatidylcholine Potentiates the Mitogenic Activity of Modified LDL for Human Monocyte–Derived Macrophages Masakazu Sakai, Akira Miyazaki, Hideki Hakamata, Arteriosclerosis Thrombosis and Vascular Biology	1996	77
Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy Takeshi Takahashi, Miyuki Yano, Minami Junko, Diabetes Research and Clinical Practice Metabolic SyndromeSarpogrelate HydrochlorideRenal FunctionMedicineDiabetes	2002	71
Serotonin enhances the production of type IV collagen by human mesangial cells Masaya Kasho, Masakazu Sakai, Takayuki Sasahara, Kidney International Tissue EngineeringDevelopmental BiologyHuman Mesangial CellsTissue PhysiologyStem Cell Research	1998	63
Effect of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus Kyoichi Suzaki, Shozo Kobori, Shin-ichiro Ueno, Atherosclerosis Cardiovascular DiseaseMedicineDiabetesGlomerular LipidosisDiabetic Kidney Disease	1990	54
Activation of acyl-coenzyme A:cholesterol acyltransferase activity by cholesterol is not due to altered mRNA levels in HepG2 cells Hirofumi Matsuda, Hideki Hakamata, Akira Miyazaki, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism	1996	40
Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan Shozo Kobori, Nobuhisa Nakamura, Haruo UZAWA, Atherosclerosis Apolipoprotein E PolymorphismMetabolic SyndromeCardiovascular DiseasePlasma LipidGenetic Epidemiology	1988	33
Glucocorticoid Inhibits Oxidized LDL-Induced Macrophage Growth by Suppressing the Expression of Granulocyte/Macrophage Colony-Stimulating Factor Masakazu Sakai, Takeshi Biwa, Takeshi Matsumura, Arteriosclerosis Thrombosis and Vascular Biology	1999	31

Page 1